Compare WYETH LTD with Panacea Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs PANACEA BIOTECH - Comparison Results

WYETH LTD     Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD PANACEA BIOTECH WYETH LTD/
PANACEA BIOTECH
 
P/E (TTM) x 27.7 11.3 245.8% View Chart
P/BV x 5.3 2.4 224.0% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 WYETH LTD   PANACEA BIOTECH
EQUITY SHARE DATA
    WYETH LTD
Mar-13
PANACEA BIOTECH
Mar-19
WYETH LTD/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs1,044354 295.4%   
Low Rs818138 591.9%   
Sales per share (Unadj.) Rs298.674.6 400.4%  
Earnings per share (Unadj.) Rs57.26.7 857.0%  
Cash flow per share (Unadj.) Rs58.415.5 377.0%  
Dividends per share (Unadj.) Rs17.000-  
Dividend yield (eoy) %1.80-  
Book value per share (Unadj.) Rs249.557.2 436.1%  
Shares outstanding (eoy) m22.7261.25 37.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.13.3 94.6%   
Avg P/E ratio x16.336.8 44.2%  
P/CF ratio (eoy) x15.915.9 100.5%  
Price / Book Value ratio x3.74.3 86.8%  
Dividend payout %29.70-   
Avg Mkt Cap Rs m21,15715,061 140.5%   
No. of employees `0000.52.3 21.3%   
Total wages/salary Rs m4001,471 27.2%   
Avg. sales/employee Rs Th13,787.41,973.6 698.6%   
Avg. wages/employee Rs Th813.0635.6 127.9%   
Avg. net profit/employee Rs Th2,643.3176.8 1,495.1%   
INCOME DATA
Net Sales Rs m6,7834,567 148.5%  
Other income Rs m35345 787.1%   
Total revenues Rs m7,1364,612 154.7%   
Gross profit Rs m1,6172,030 79.7%  
Depreciation Rs m27540 4.9%   
Interest Rs m61,048 0.5%   
Profit before tax Rs m1,938486 398.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m63277 820.0%   
Profit after tax Rs m1,301409 317.9%  
Gross profit margin %23.844.4 53.6%  
Effective tax rate %32.615.9 205.7%   
Net profit margin %19.29.0 214.0%  
BALANCE SHEET DATA
Current assets Rs m6,9842,415 289.2%   
Current liabilities Rs m2,0569,077 22.6%   
Net working cap to sales %72.6-145.9 -49.8%  
Current ratio x3.40.3 1,277.1%  
Inventory Days Days9965 152.5%  
Debtors Days Days2471 33.8%  
Net fixed assets Rs m2448,333 2.9%   
Share capital Rs m22761 370.6%   
"Free" reserves Rs m5,4413,443 158.0%   
Net worth Rs m5,6683,504 161.8%   
Long term debt Rs m25461 5.4%   
Total assets Rs m7,90113,755 57.4%  
Interest coverage x353.31.5 24,137.7%   
Debt to equity ratio x00.1 3.4%  
Sales to assets ratio x0.90.3 258.6%   
Return on assets %16.510.6 156.0%  
Return on equity %22.911.7 196.5%  
Return on capital %34.038.7 88.0%  
Exports to sales %0.220.9 1.0%   
Imports to sales %36.38.1 446.3%   
Exports (fob) Rs m15954 1.6%   
Imports (cif) Rs m2,465372 662.9%   
Fx inflow Rs m151,203 1.3%   
Fx outflow Rs m2,677467 573.7%   
Net fx Rs m-2,662736 -361.5%   
CASH FLOW
From Operations Rs m9231,049 88.0%  
From Investments Rs m317-54 -592.3%  
From Financial Activity Rs m-481-1,011 47.6%  
Net Cashflow Rs m759-20 -3,853.3%  

Share Holding

Indian Promoters % 0.0 74.5 -  
Foreign collaborators % 51.1 0.0 -  
Indian inst/Mut Fund % 11.3 0.6 1,883.3%  
FIIs % 7.2 1.3 553.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 23.6 128.8%  
Shareholders   21,978 10,259 214.2%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   SUN PHARMA  DR. REDDYS LAB  ABBOTT INDIA  UNICHEM LAB  PROCTER & GAMBLE HEALTH  

Compare WYETH LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 21 Points Higher; Banking and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours today and ended their day marginally higher.

Related Views on News

PANACEA BIOTECH 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of PANACEA BIOTECH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PANACEA BIOTECH. Also includes updates on the valuation of PANACEA BIOTECH.

PANACEA BIOTECH Announces Quarterly Results (3QFY19); Net Profit Down 137.1% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, PANACEA BIOTECH has posted a net profit of Rs 230 m (down 137.1% YoY). Sales on the other hand came in at Rs 1 bn (down 25.2% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

PANACEA BIOTECH Announces Quarterly Results (2QFY19); Net Profit Down 1631.6% (Quarterly Result Update)

Nov 27, 2018 | Updated on Nov 27, 2018

For the quarter ended September 2018, PANACEA BIOTECH has posted a net profit of Rs 975 m (down 1631.6% YoY). Sales on the other hand came in at Rs 1 bn (down 22.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

PANACEA BIOTECH Announces Quarterly Results (4QFY18); Net Profit Down 66.5% (Quarterly Result Update)

Jun 20, 2018 | Updated on Jun 20, 2018

For the quarter ended March 2018, PANACEA BIOTECH has posted a net profit of Rs 86 m (down 66.5% YoY). Sales on the other hand came in at Rs 2 bn (up 0.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Ditch the Risky Fixed Deposits for Safer 'Bluechip Deposits'(Profit Hunter)

Oct 30, 2019

Most people think stocks are riskier than fixed deposits and bonds. The last quarter century proves otherwise.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD 8-QTR ANALYSIS

COMPARE WYETH LTD WITH

MARKET STATS